GPT and osteosarcoma: Among the ALT osteosarcoma cell lines, U2OS had the lowest response to ponatinib treatment (Fig. 1b and Supplementary Fig. 5b), while still showing a moderate increase in telomeric C-circle levels after treatment (Fig. 1d).